Javier Aspa

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

Jacobo Rogado, J.M. Sánchez-Torres, Nuria Romero-Laorden et al. · European Journal of Cancer · 2019 · 261 citations

Life Sciences, Immunology, Oncology +17

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

José María Galván‐Román, S. C. Rodriguez-García, Emilia Roy‐Vallejo et al. · Journal of Allergy and Clinical Immunology · 2020 · 238 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

José Curbelo, Sergio Luquero‐Bueno, José María Galván‐Román et al. · PLoS ONE · 2017 · 167 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Guidelines for the Treatment of Community-acquired Pneumonia

Rosario Menéndez, Antoni Torres, Rafael Zalacaín et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 158 citations · Full text

Pharmacy, Community Medicine, Antimicrobial Pharmacotherapy +16

Reaching Stability in Community-Acquired Pneumonia: The Effects of the Severity of Disease, Treatment, and the Characteristics of Patients

Rosario Menéndez, Antoni Torres, Felipe Rodrı́guez de Castro et al. · Clinical Infectious Diseases · 2004 · 138 citations · Full text

Veterinary Medicine, Infectious Diseases, Pulmonary Function Testing +13